Schoenmaekers J, Dijkstra J, van der Wekken A, Paats M, et al. In-depth Analysis of Lorlatinib-related neurocognitive Adverse Events in Patients With Non-small-cell Lung Cancer. Clin Lung Cancer 2023 Dec 13:S1525-7304(23)00261.
PMID: 38151408